PDG9 Cost Effectiveness Analysis of Blonanserin Versus Olanzapine As First-LINE Treatment for Patients with Schizophrenia in China
Abstract
Authors
L.Y. Wang Y. Cao F.H. Shi H. Xu X. Guan H.C. Li J. Liu H. Qian
L.Y. Wang Y. Cao F.H. Shi H. Xu X. Guan H.C. Li J. Liu H. Qian
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now